Melatonin treatment in peri- and postmenopausal women elevates serum high-density lipoprotein cholesterol levels without influencing total cholesterol levels

Journal of Pineal Research

Volumn 45, Issue 1, 2008, Pages 101-105

  Tamura, Hiroshi ^a,b   Nakamura, Yasuhiko ^c   Narimatsu, Akio ^d   Yamagata, Yoshiaki ^a   Takasaki, Akihisa ^e   Reiter, Russel J ^b   Sugino, Norihiro ^a  

^a YAMAGUCHI UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b University of Texas Health Science Center at San Antonio   (United States)

^c Yamaguchi Grand Medical Center   (Japan)

^d Ogori Daiichi General Hospital   (Japan)

^e Saiseikai Shimonoseki General Hospital   (Japan)

Author keywords

Cardiovascular disease; High density lipoprotein cholesterol; Lipid metabolism; Melatonin; Menopause

Indexed keywords

HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; MELATONIN; TRIACYLGLYCEROL;

ADULT; AGED; ARTICLE; CARDIOVASCULAR DISEASE; CHOLESTEROL BLOOD LEVEL; CHOLESTEROL METABOLISM; CLIMACTERIUM; CONTROLLED STUDY; DRUG EFFECT; DRUG EFFICACY; DRUG POTENCY; FEMALE; HEART PROTECTION; HORMONE BLOOD LEVEL; HUMAN; HUMAN EXPERIMENT; LIPID METABOLISM; LIPOPROTEIN BLOOD LEVEL; NORMAL HUMAN; POSTMENOPAUSE; TRIACYLGLYCEROL BLOOD LEVEL;

ADULT; AGED; CHOLESTEROL, HDL; CHOLESTEROL, LDL; FEMALE; HUMANS; MELATONIN; MIDDLE AGED; PERIMENOPAUSE; POSTMENOPAUSE; TRIGLYCERIDES;

EID: 47249124459     PISSN: 07423098     EISSN: 1600079X     Source Type: Journal    
DOI: 10.1111/j.1600-079X.2008.00561.x     Document Type: Article

References (47)

1. Castelli W. Epidemiology of coronary heart disease: the Framingham Study. Am J Med 1984 76 : 4 12.
2. Jensen J, Nilis L, Christiansen C. Influence of menopause on serum lipids and lipoproteins. Maturitas 1990 12 : 321 331.
3. Stevenson JC, Crook D, Godsland IF. Influence of age and menopause on serum lipids and lipoproteins in healthy women. Athrosclerosis 1993 98 : 83 90.
4. Reiter RJ. Melatonin: the chemical expression of darkness. Mol Cell Endocrinol 1991 79 : C153 C158.
5. Reiter RJ. The melatonin message: duration versus coincidence hypotheses. Life Sci 1987 40 : 2119 2131.
6. Tamura H, Nakamura Y, Takiguchi S et al. Melatonin directly suppresses steroid production by preovulatory follicles in the cyclic hamster. J Pineal Res 1998 25 : 135 141.
7. Garfinkel D, Laudon M, Nof D, Zisapel N. Improvement of sleep quality in elderly people by controlled release melatonin. Lancet 1995 346 : 541 543.
8. Kennaway DJ, Wright H. Melatonin and circadian rhythms. Curr Top Med Chem 2002 2 : 199 209.
9. Blask DE, Dauchy RT, Sauer LA. Putting cancer to sleep at night: the neuroendocrine/circadian melatonin signal. Endocrine 2005 27 : 179 188.
10. Rubio S, Estevez F, Cabrera J, Reiter RJ, Loro J, Quintana J. Inhibition of proliferation and induction of apoptosis by melatonin in human myeloid HL-60 cells. J Pineal Res 2007 42 : 131 138.
11. Letechipia-Vallejo G, Lopez-Loeza E, Espinoza-Gonzalez V et al. Long-term morphological and functional evaluation of the neuroprotective effects of post-ischemic treatment with melatonin in rats. J Pineal Res 2007 42 : 138 146.
12. Maldonado MD, Murillo-Cabezas F, Terron MP et al. The potential of melatonin in reducing morbidity-mortality after craniocerebral trauma. J Pineal Res 2007 42 : 1 11.
13. Tan DX, Manchester LC, Terron MP, Flores LJ, Reiter RJ. One molecule, many derivatives: a never-ending interaction of melatonin with reactive oxygen and nitrogen species? J Pineal Res 2007 42 : 28 42.
14. Manda K, Ueno M, Anzai K. AFMK, a melatonin metabolite, attenuates X-ray-induced oxidative damage to DNA, proteins and lipids in mice. J Pineal Res 2007 42 : 386 393.
15. Nakamura Y, Tamura H, Kashida S et al. Changes of serum melatonin level and its relationship to feto-placental unit during pregnancy. J Pineal Res 2001 30 : 29 33.
16. Aoyama H, Mori N, Mori W. Effects of melatonin on genetic hypercholesterolemia in rats. Atherosclerosis 1988 69 : 269 272.
17. Mori N, Aoyama H, Naruse T, Mori W. Anti-hypercholesterolemic effect of melatonin in rats. Acta Pathol Jpn 1989 39 : 613 618.
18. Chan TY, Tang PL. Effect of melatonin on the maintenance of cholesterol homeostasis in the rat. Endocr Res 1995 21 : 681 696.
19. Tamura H, Nakamura Y, Takiguchi S et al. Pinealectomy or melatonin implantation does not affect prolactin surge or luteal function in pseudopregnant rats. Endocrine J 1998 45 : 377 383.
20. Grodstein F, Stampfer MJ, Manson JE. Postmenopausal estrogen and progestin use and the risk of cardiovascular disease. N Engl J Med 1996 335 : 453 461.
21. Schairer C, Adami HO, Hoover R, Persson I. Cause-specific mortality in women receiving hormone replacement therapy. Epidemiology 1997 8 : 59 65.
22. Lacey JV Jr., Brinton LA, Lubin JH, Sherman ME, Schatzkin A, Schairer C. Endometrial carcinoma risks among menopausal estrogen plus progestin and unopposed estrogen users in a cohort of postmenopausal women. Cancer Epidemiol Biomarkers Prev 2005 14 : 1724 1731.
23. Chen CL, Weiss NS, Newcomb P, Barlow W, White E. Hormone replacement therapy in relation to breast cancer. JAMA 2002 287 : 734 741.
24. Jan JE, Wasdell MB, Freeman RD, Bax M. Evidence supporting the use of melatonin in short gestation infants. J Pineal Res 2007 42 : 22 27.
25. Reiter RJ, Tan DX, Sainz RM, Mayo JC, Lopez-Burillo S. Melatonin: reducing the toxicity and increasing the efficacy of drugs. J Pharm Pharmacol 2002 54 : 1299 1321.
26. Kurth T, Everett BM, Buring JE, Kase CS, Ridker PM, Gaziano JM. Lipid levels and the risk of ischemic stroke in women. Neurology 2007 68 : 556 562.
27. Leppala JM, Virtamo J, Fogelholm R, Albanes D, Heinonen OP. Different risk factors for different stroke subtypes: association of blood pressure, cholesterol, and antioxidants. Stroke 1999 30 : 2535 2540.
28. Koren-Morag N, Tanne D, Graff E, Goldbourt U. Low- and high-density lipoprotein cholesterol and ischemic cerebrovascular disease: the bezafibrate infarction prevention registry. Arch Intern Med 2002 162 : 993 999.
29. Wannamethee SG, Shaper AG, Ebrahim S. HDL-cholesterol, total cholesterol, and the risk of stroke in middle-aged British men. Stroke 2000 31 : 1882 1888.
30. Sacco RL, Benson RT, Kargman DE et al. High-density lipoprotein cholesterol and ischemic stroke in the elderly: the Northern Manhattan Stroke Study. JAMA 2001 285 : 2729 2735.
31. Hussain SA. Effect of melatonin on cholesterol absorption in rats. J Pineal Res 2007 42 : 267 271.
32. Esquifino A, Agrasal C, Velazquez E, Villanua MA, Cardinali DP. Effect of melatonin on serum cholesterol and phospholipid levels, and on prolactin, thyroid-stimulating hormone and thyroid hormone levels, in hyperprolactinemic rats. Life Sci 1997 61 : 1051 1058.
33. Arias J, Melean E, Valero N et al. Effect of melatonin on lymphocyte proliferation and production of interleukin-2 (IL-2) and interleukin-1 beta (IL-1 beta) in mice splenocytes. Invest Clin 2003 44 : 41 50.
34. Del Gobbo V, Libri V, Villani N, Calio R, Nistico G. Pinealectomy inhibits interleukin-2 production and natural killer activity in mice. Int J Immunopharmacol 1989 11 : 567 571.
35. Lissoni P, Barni S, Tancini G, Fossati V, Frigerio F. Pineal-opioid system interactions in the control of immunoinflammatory responses. Ann NY Acad Sci 1994 741 : 191 196.
36. Arendt J, Aldhous M, Wright J. Synchronisation of a disturbed sleep-wake cycle in a man by melatonin treatment. Lancet 1988 1 : 772 773.
37. Petrie K, Dawson AG, Thompson L, Brook R. A double-blind trial of melatonin as a treatment for jet lag in international cabin crew. Biol Psychiatry 1993 33 : 526 530.
38. Sparrow CP, Parthasarathy S, Steinberg D. A macrophage receptor that recognizes oxidized low density lipoprotein but not acetylated low density lipoprotein. J Biol Chem 1989 264 : 2599 2604.
39. Reiter RJ, Tan DX, Poeggeler B, Menendez-Pelaez A, Chen LD, Saarela S. Melatonin as a free radical scavenger: implications for aging and age-related disease. Ann NY Acad Sci 1994 719 : 1 12.
40. Allegra M, Reiter RJ, Tan DX, Gentile C, Tesoriere L, Livrea MA. The chemistry of melatonin's interaction with reactive species. J Pineal Res 2003 34 : 1 10.
41. Tan DX, Chen LD, Poeggeler B, Manchester LC, Reiter RJ. Melatonin: a potent, endogenous hydroxyl radical scavenger. Endocrine J 1993 1 : 57 60.
42. Pieri C, Marra M, Moroni F, Recchioni R, Marcheselli F. Melatonin: a peroxyl radical scavenger more effective than vitamin E. Life Sci 1994 55 : PL271 PL276.
43. Cuzzocrea S, Zingarelli B, Gilad E, Hake P, Salzman AL, Szabo C. Protective effect of melatonin in carrageenan-induced models of inflammation: relationship to its inhibitory effect on nitric oxide production and its peroxinitrite scavenging activity. J Pineal Res 1997 23 : 106 116.
44. Pieri C, Marra M, Gaspar R, Damjanovich S. Melatonin protects LDL from oxidation but does not prevent the apolipoprotein derivatization. Biochem Biophys Res Commun 1996 222 : 256 260.
45. Kelly MR, Loo G. Melatonin inhibits oxidative modification of human low-density lipoprotein. J Pineal Res 1997 22 : 203 209.
46. Seegar H, Mueck AO, Lippert TH. Effect of melatonin and metabolites on copper-mediated oxidation of low density lipoprotein. Br J Clin Pharmacol 1997 44 : 283 284.
47. Simko F, Paulis L. Melatonin as a potential antihypertensive treatment. J Pineal Res 2007 42 : 319 322.